Primary adenocarcinoma of the seminal vesicle

Safae Terrisse; Maria Eugenia Camblor; Jérôme Vérine; Hélène Gauthier; Pierre Mongiat-Artus; Stéphane Culine

doi:10.4081/rt.2017.7074

Primary adenocarcinoma of the seminal vesicle

Rare Tumors. 2017 Oct 3;9(3):7074. doi: 10.4081/rt.2017.7074.

Authors

Safae Terrisse^{1

2}, Maria Eugenia Camblor³, Jérôme Vérine^{2

4}, Hélène Gauthier¹, Pierre Mongiat-Artus^{2

5}, Stéphane Culine^{1

2}

Affiliations

¹ Department of Medical Oncology, Hôpital Saint-Louis, APHP, Paris, France.
² Paris Diderot University, Sorbonne Paris Cité, Paris, France.
³ Servicio de Oncologia Clinica. Hospital de Clinicas, Montevideo, Uruguay.
⁴ Department of Anatomic-Pathology, Hopital Saint-Louis, APHP, Paris, France.
⁵ Department of Urology, Hôpital Saint-Louis, APHP, Paris, France.

Abstract

Primary adenocarcinoma of the seminal vesicle is a rare condition with only about 60 cases described in the literature. The unusual characteristics of this disease makes diagnosis difficult and treatment strategies differ as there are no specific guidelines available. This report presents a case of adenocarcinoma of the seminal vesicle with lung metastases in which surgical and chemotherapeutic treatments have been carried out. The MVAC dose dense regimen following local resection seems effective in this scenario and may be used in the treatment of this disease.

Keywords: carcinoma; chemotherapy; lung metastasis; remission; seminal vesicle.